✦ LIBER ✦

Commentary: BMI and the need for adalimumab dose escalation in Crohn's disease – authors’ reply

✍ Scribed by E. Bultman; C. J. van der Woude

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Commentary: BMI and the need for adalimu

✍ G. Van Assche; F. Baert; S. Vermeire 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 52 KB

Infliximab dose escalation vs. initiatio

✍ G. G. KAPLAN; C. HUR; J. KORZENIK; B. E. SANDS 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 293 KB

Early clinical remission and normalisati

✍ L. S. Kiss; T. Szamosi; T. Molnar; P. Miheller; L. Lakatos; A. Vincze; K. Palatk 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 191 KB